课题基金 / 基金详情

项目摘要

项目成果

DEXI LIU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Development of new and improved methods for a safe, site specific and efficient gene delivery has become a major focus in gene therapy research. To accelerate the process, we have developed a computer-controlled injection device for hydrodynamic gene delivery to different organs in vivo, particularly to liver. Employing an image-guided catheter insertion technique, we have demonstrated in pigs that the computer-assisted hydrodynamic gene delivery to pig liver is effective and safe. In the study outlined in this proposal, we will evaluate the effectiveness and safety of our newly developed gene delivery system for treatment of hemophilia B using hemophilia B dogs as an animal model. The overall objective of the proposed study is to establish a minimally invasive, reliable and safe procedure for human gene therapy. In specific aim 1, we will employ the procedure of image-guided, liver specific hydrodynamic gene delivery to optimize the hydrodynamic parameters for gene delivery to dog liver. In specific aim 2, we will characterize the long-term impact of the hydrodynamic gene delivery with respect to persistence of transgene expression, effect on tissue toxicity, potential immune response against transgene product, and tissue distribution of the transgene. Specific aim 3 was designed to assess the effectiveness of repeated hydrodynamic gene delivery to the same animals. In specific aim 4, we will perform pre-clinical evaluation of the optimized procedure for treatment of hemophilia in hemophilia B dogs and characterize the long-term effects of the treatment. This translational research is designed to validate a newly developed computer-controlled device for gene delivery and to establish a clinically applicable procedure. Data collected from the study will be critical for preparation of clinical trials. If successfully accomplished, the proposed study will provide a new technology for gene delivery and will significantly advance the field of gene therapy.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s11095-013-1125-1
发表时间: 2013-11
期刊: PHARMACEUTICAL RESEARCH
影响因子: 3.7
作者: [Gao, Mingming, Ma, Yongjie, Liu, Dexi]
通讯作者: Liu, Dexi
DOI: --
发表时间: 2014-06
期刊: Discovery medicine
影响因子: 1.4
作者: [Mingming Gao;Dexi Liu]
通讯作者: Mingming Gao;Dexi Liu
DOI: 10.1007/s11095-010-0338-9
发表时间: 2011-04
期刊: PHARMACEUTICAL RESEARCH
影响因子: 3.7
作者: [Bonamassa, Barbara, Hai, Li, Liu, Dexi]
通讯作者: Liu, Dexi
IL-15/sIL-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys.
IL-15/sIL-15Rα 基因转移抑制路易斯肺癌在肺、肝和肾中的生长。
DOI: 10.1038/cgt.2015.67
发表时间: 2016
期刊: Cancer gene therapy
影响因子: 6.4
作者: [Sun,H, Liu,D]
通讯作者: Liu,D
22
    Computer-Assisted Hydrodynamic Gene Delivery for Hemophilia Gene Therapy
    Computer-Assisted Hydrodynamic Gene Delivery for Hemophilia Gene Therapy
    • 批准号:
      8197392
    • 项目类别:
    • 资助金额:
      $51.54万
    • 财政年份:
      2009
    • 负责人:
      DEXI LIU
    • 依托单位:
    Computer-Assisted Hydrodynamic Gene Delivery for Hemophilia Gene Therapy
    Image-Guided Hydrodynamic Gene Delivery
    海外基金